Multiple tumor-associated signaling pathways

"Multiple tumor-associated signaling pathways" refers to the complex, interrelated cascades of protein-protein interactions, post-translational modifications, and transcriptional networks that regulate cancer cell growth, survival, migration, immune evasion, and adaptation to microenvironmental cues. Major pathways include, but are not limited to, the MAPK/ERK, PI3K/Akt/mTOR, JAK/STAT, Wnt/β-catenin, Notch, and TGF-β signaling cascades, each of which regulates key functional processes in tumor initiation, progression, and metastasis. Because these signaling pathways are interconnected, redundancy and feedback loops often lead to therapy resistance if only a single pathway is targeted. Thus, modern therapeutic strategies often employ multi-targeted or combination approaches to effectively interfere with cancer cell growth and overcome adaptive resistance mechanisms. This entry is not suitable as a canonical molecular target; more specificity is required (such as listing "Epidermal growth factor receptor" or "Phosphoinositide 3-kinase alpha"). "Multiple tumor-associated signaling pathways" describes a functional category rather than a molecular entity or unified drug target.

Other names

Tumor signaling pathwaysCancer-associated signaling networksOncogenic signaling cascades

Inhibition of kinase activity (e.g., blocking phosphorylation events to prevent signal transduction). Blocking receptor activation. Interrupting downstream signaling necessary for tumor growth and survival. Modulation of transcription factor activity. Modulating metabolic pathways.